FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TIROSINT (levothyroxine sodium) submitted by IBSA Pharma Inc., updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Goiter
• Hypothyroidism

Drugs mentioned

• TIROSINT (Levothyroxine Sodium)

Snippet

SUPPL AP for TIROSINT (LEVOTHYROXINE SODIUM)